Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups ...

The fresh capital provides another shot for Moderna's candidate against bird flu, which earlier this year lost its government ...

The Coalition for Epidemic Preparedness Innovations said it will invest $54.3 million with Moderna to fund a Phase 3 trial of ...

Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental ...

Since he entered politics, President Donald Trump has been a regular on our end-of-year list of the most egregious and ...

As support from the U.S. government has evaporated, Moderna is leaning on an old ally to carry plans for its prospective mRNA ...

Moderna (MRNA) stock is in focus as CEPI vaccine coalition agreed to invest up to $54.3M to support a late-stage trial for the company's bird flu shot. Read more here.

Up to $54.3 million CEPI investment aims to help advance Moderna's H5 pandemic influenza vaccine candidate to licensure ...

Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...

People familiar with the plan told CNN the FDA is weighing whether to place a black box warning on COVID vaccines. These warnings appear at the top of drug labels and are typically reserved for ...

The COVID-19 vaccines developed for the 2024-2025 respiratory disease season were around 75% effective at preventing ...

The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...